Number of the records: 1  

Cell-type specific anti-cancerous effects of nitro-oleic acid and its combination with gamma irradiation

  1. 1.
    SYSNO ASEP0583536
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleCell-type specific anti-cancerous effects of nitro-oleic acid and its combination with gamma irradiation
    Author(s) Perečko, Tomáš (BFU-R) RID, ORCID
    Perečková, Jana (BFU-R) ORCID
    Hoferová, Zuzana (BFU-R) RID
    Falk, Martin (BFU-R) RID, ORCID
    Number of authors4
    Source TitleBiological Chemistry. - : Walter de Gruyter - ISSN 1431-6730
    Roč. 2023, SEP 15 2023 (2023)
    Number of pages11 s.
    Publication formOnline - E
    Languageeng - English
    CountryDE - Germany
    Keywordsconjugated linoleic-acid ; fatty-acids ; radiation ; oxide ; radiosensitivity ; apoptosis ; sensitivity
    Subject RIVCE - Biochemistry
    OECD categoryBiochemistry and molecular biology
    Method of publishingLimited access
    Institutional supportBFU-R - RVO:68081707
    UT WOS001067412100001
    EID SCOPUS85171733621
    DOI10.1515/hsz-2023-0150
    AnnotationNitro-fatty acids (NFAs) are endogenous lipid mediators capable of post-translational modifications of selected regulatory proteins. Here, we investigated the anti-cancerous effects of nitro-oleic acid (NO(2)OA) and its combination with gamma irradiation on different cancer cell lines. The effects of NO(2)OA on cell death, cell cycle distribution, or expression of p21 and cyclin D1 proteins were analyzed in cancer (A-549, HT-29 and FaDu) or normal cell lines (HGF, HFF-1). Dose enhancement ratio at 50?% survival fraction (DERIC50) was calculated for samples pre-treated with NO(2)OA followed by gamma irradiation. NO(2)OA suppressed viability and induced apoptotic cell death. These effects were cell line specific but not in general selective for cancer cells. HT-29 cell line exerted higher sensitivity toward NO(2)OA treatment among cancer cell lines tested: induction of cell cycle arrest in the G2/M phase was associated with an increase in p21 and a decrease in cyclin D1 expression. Pre-treatment of HT-29 cells with NO(2)OA prior irradiation showed a significantly increased DERIC50, demonstrating radiosensitizing effects. In conclusion, NO(2)OA exhibited potential for combined chemoradiotherapy. Our results encourage the development of new NFAs with improved features for cancer chemoradiation.
    WorkplaceInstitute of Biophysics
    ContactJana Poláková, polakova@ibp.cz, Tel.: 541 517 244
    Year of Publishing2024
    Electronic addresshttps://www.degruyter.com/document/doi/10.1515/hsz-2023-0150/html
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.